A systematic review of each of the original groupings of people on the Highest Risk List pinpoints the groups which clinicians advise now have a significantly reduced risk, and the groups which still have a higher level of risk. We will publish separate guidance for these two groups.
The groups of people who do still have a higher risk are as follows:
- Group 1 – Transplant
- Group 2 – Cancer
- Group 5 - Immunosuppression
This review supports the conclusion that there is no longer a purpose for, or need to retain the Highest Risk List.
There is a problem
Thanks for your feedback